BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 35926810)

  • 21. Mucinous carcinomas of the gallbladder: clinicopathologic analysis of 15 cases identified in 606 carcinomas.
    Dursun N; Escalona OT; Roa JC; Basturk O; Bagci P; Cakir A; Cheng J; Sarmiento J; Losada H; Kong SY; Ducato L; Goodman M; Adsay NV
    Arch Pathol Lab Med; 2012 Nov; 136(11):1347-58. PubMed ID: 23106580
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Mucinous adenocarcinoma of the prostate. A case report and analysis of the literature].
    Watarai Y; Demura T; Togashi M; Ohashi N; Chikaraishi T; Hirano T; Fukazawa Y
    Nihon Hinyokika Gakkai Zasshi; 1994 Aug; 85(8):1276-9. PubMed ID: 7523749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mesonephric remnant hyperplasia involving prostate and periprostatic tissue: findings at radical prostatectomy.
    Chen YB; Fine SW; Epstein JI
    Am J Surg Pathol; 2011 Jul; 35(7):1054-61. PubMed ID: 21606823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nephrogenic adenoma of the prostatic urethra: a mimicker of prostate adenocarcinoma.
    Allan CH; Epstein JI
    Am J Surg Pathol; 2001 Jun; 25(6):802-8. PubMed ID: 11395559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ovarian mucinous tumors associated with mature cystic teratomas: morphologic and immunohistochemical analysis identifies a subset of potential teratomatous origin that shares features of lower gastrointestinal tract mucinous tumors more commonly encountered as secondary tumors in the ovary.
    Vang R; Gown AM; Zhao C; Barry TS; Isacson C; Richardson MS; Ronnett BM
    Am J Surg Pathol; 2007 Jun; 31(6):854-69. PubMed ID: 17527072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mucinous adenocarcinoma of prostate and prostatic adenocarcinoma with mucinous components: a clinicopathological analysis of 143 cases.
    Samaratunga H; Delahunt B; Srigley JR; Yaxley J; Johannsen S; Coughlin G; Gianduzzo T; Kua B; Patterson I; Nacey JN; Egevad L
    Histopathology; 2017 Oct; 71(4):641-647. PubMed ID: 28590015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Colorectal adenocarcinoma involving the prostate: report of 9 cases.
    Osunkoya AO; Netto GJ; Epstein JI
    Hum Pathol; 2007 Dec; 38(12):1836-41. PubMed ID: 17868775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urothelial-type adenocarcinoma of the prostate mimicking metastatic colorectal adenocarcinoma.
    Adley BP; Maxwell K; Dalton DP; Yang XJ
    Int Braz J Urol; 2006; 32(6):681-7; discussion 687-8. PubMed ID: 17201946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostatic Adenocarcinoma With Focal Pleomorphic Giant Cell Features: A Series of 30 Cases.
    Alharbi AM; De Marzo AM; Hicks JL; Lotan TL; Epstein JI
    Am J Surg Pathol; 2018 Oct; 42(10):1286-1296. PubMed ID: 29944471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Mucinous adenocarcinoma of the prostate: a case report and review of 32 cases on immunohistochemical study of both PSA and CEA].
    Furuta A; Naruoka T; Hasegawa N; Suzuki Y; Ikemoto I; Oishi Y
    Nihon Hinyokika Gakkai Zasshi; 2003 Jul; 94(5):570-3. PubMed ID: 12910933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aggressive prostatic adenocarcinoma with urothelial-like morphology, with frequent CK7/CK20/HMWK expression and occasional diffuse neuroendocrine features: A clinicopathologic study of 12 cases.
    Nguyen NJ; Sherman C; van der Kwast TH; Downes MR
    Pathol Res Pract; 2024 Feb; 254():155105. PubMed ID: 38218041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MUC2 expression in primary mucinous and nonmucinous adenocarcinoma of the prostate: an analysis of 50 cases on radical prostatectomy.
    Osunkoya AO; Adsay NV; Cohen C; Epstein JI; Smith SL
    Mod Pathol; 2008 Jul; 21(7):789-94. PubMed ID: 18487999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ERG expression in mucinous prostatic adenocarcinoma and prostatic adenocarcinoma with mucinous features: comparison with conventional prostatic adenocarcinoma.
    Johnson H; Zhou M; Osunkoya AO
    Hum Pathol; 2013 Oct; 44(10):2241-6. PubMed ID: 23849895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prostatic adenocarcinoma with mucinous features: A review of the literature with three case reports.
    Karsiyakali N; Karabay E; Yucetas U; Koca SB; Akay AF; Kadihasanoglu M
    J Cancer Res Ther; 2021; 17(2):596-598. PubMed ID: 34121718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mucinous adenocarcinoma of the prostate: histochemical and immunohistochemical studies.
    Ro JY; Grignon DJ; Ayala AG; Fernandez PL; Ordonez NG; Wishnow KI
    Hum Pathol; 1990 Jun; 21(6):593-600. PubMed ID: 1693591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mucin-producing urothelial-type adenocarcinoma of the prostate as a mimicker of colonic adenocarcinoma: a case report and review of the literature.
    Chen YL; Chian JH; Hsiao PJ
    Int J Surg Pathol; 2012 Apr; 20(2):191-5. PubMed ID: 21791488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intestinal-type cervical adenocarcinoma in situ and adenocarcinoma exhibit a partial enteric immunophenotype with consistent expression of CDX2.
    McCluggage WG; Shah R; Connolly LE; McBride HA
    Int J Gynecol Pathol; 2008 Jan; 27(1):92-100. PubMed ID: 18156982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cdx2, cytokeratin 20, thyroid transcription factor 1, and prostate-specific antigen expression in unusual subtypes of prostate cancer.
    Leite KRM; Mitteldorf CATS; Srougi M; Dall'Oglio MF; Antunes AA; Pontes J; Camara-Lopes LH
    Ann Diagn Pathol; 2008 Aug; 12(4):260-266. PubMed ID: 18620992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Two cases of mucinous adenocarcinoma of the prostate].
    Ishibashi Y; Kishida T; Yamaguchi T; Sugawara T; Satomi Y
    Hinyokika Kiyo; 1992 Apr; 38(4):463-7. PubMed ID: 1326881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Case Report: Prostate Adenocarcinoma With Mucinous Features of Normal-Level Serum PSA, Atypical Imaging, Biopsy-Negative, and Peculiar Urethrocystoscopic Manifestation.
    Zhang Y; Shen H; Liao K; Wu W; Li J; Yu H; Wu H; Wang Z
    Front Oncol; 2020; 10():504381. PubMed ID: 33425711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.